Results 201 to 210 of about 53,162 (283)

Optimized strategy of switching to tenofovir alafenamide fumarate treatment for nucleos(t)ide analogue experienced patients with chronic hepatitis B. [PDF]

Front Med (Lausanne)
Hu X, Kong Y, Liu Y, Liu T, Ma A, Li Y, Zhang Y, Li J, Zhang L, Li G.   +9 more
europepmc   +1 more source

Seroprevalence of Hepatitis B Virus Carriage Markers Among Students at the University of Yaoundé II, Cameroon. [PDF]

Biomed Res Int
Serge AOD, Flora MM, Gueguim C, Akono L, Adiogo D.   +4 more
europepmc   +1 more source

Chronic hepatitis B in 2025: diagnosis, treatment and future directions. [PDF]

Clin Med (Lond)
Watson AG, Mulay AS, Gill US.
europepmc   +1 more source

Complete response and HBsAg clearance of advanced hepatocellular carcinoma associated with hepatitis B by DEB-TACE combined systematic therapy: a case report. [PDF]

Front Immunol
Xu B, Cui Y, Cui H, Wang N, Gao Z, Ye Q.
europepmc   +1 more source

Association of leukocyte telomere length with anti-HBsAg antibody titer in Hepatitis-B recovered patients from the Pakistani population. [PDF]

BMC Infect Dis
Qamar A, Hui L, Khan S, Bin Khalid A, Hu D.   +4 more
europepmc   +1 more source

Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study. [PDF]

J Glob Health
Pascucci D, Nicolàs A, Taha A, Lazarus JV, Di Pumpo M, Tricomi V, Di Berardino F, La Vecchia C, Perez-Molina JA, Colucci G, Picchio CA, Pezzullo AM, Boccia S.   +12 more
europepmc   +1 more source

Comprehensive evaluation of NAT+/HBsAg- blood donors: confirmation strategies, serial testing outcomes, and S gene mutations associated with occult HBV infection. [PDF]

BMC Infect Dis
Du R, Gao W, Li Z, Liang H, Liao F, Xie J, Li F, Wan Z, Li S, Xu R, Fu Y, Nie Y, Wang H, Liang H.   +13 more
europepmc   +1 more source

Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.

, 1985
Staffan Sylvan, Ulla Hellström, P Lundbergh   +2 more
openalex   +1 more source

The interferon-inducible MxB large GTPase attenuates hepatitis B virus replication by activating the RIG-I innate immunity signaling pathway. [PDF]

Sci Rep
Onuki M, Inoue J, Doi K, Ninomiya M, Sano A, Tsuruoka M, Sato K, Sawahashi S, Ouchi K, Watanabe K, McNiven MA, Masamune A.   +11 more
europepmc   +1 more source